Biofrontera BFRI
NASDAQ BFRI
$1.48 +0.06 (+4.23%)
At close: Aug 20, 2026 · 4:00 PM EDT

Biofrontera (BFRI) EBT Margin (2020 - 2026)

Biofrontera (BFRI) posted quarterly EBT Margin of 32.98% for Q4 2025, up 4412.0% year-over-year from 0.73% in Q4 2024, and up 134.7% quarter-over-quarter from 95.06% in Q3 2025.

Biofrontera (BFRI) EBT Margin (2020 - 2026) Analysis & Trends

Biofrontera's EBT Margin history runs 6 years deep, the most recent figure standing at 32.98% for Q4 2025.

  • In Q4 2025, EBT Margin rose 4412.0% year-over-year to 32.98%; the TTM figure through Dec 2025 stood at 25.2% (up 2233.0% YoY), while the FY2025 annual figure was 25.2%, up 2232.0% from the prior year.
  • EBT Margin for Q4 2025 stood at 32.98%, up from 95.06% in the prior quarter.
  • The five-year high for EBT Margin was 97.48% in Q4 2021, with the low at 369.31% in Q3 2021.
  • The 5-year median for EBT Margin is 59.04% (2022), against an average of 56.35%.
  • The sharpest annual moves came in 2021 and 2022: EBT Margin tumbled 27940 bps in 2021, then surged 30996 bps in 2022.
  • Biofrontera's EBT Margin stood at 97.48% in 2021, then plunged by 128 bps to 27.44% in 2022, then soared by 221 bps to 33.22% in 2023, then plunged by 134 bps to 11.14% in 2024, then surged by 396 bps to 32.98% in 2025.
  • Business Quant data shows BFRI's EBT Margin at 32.98% in Q4 2025, 95.06% in Q3 2025, and 58.73% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -10.99%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 47.58%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Biofrontera 18.87 Mn 14.16 Mn 9.59 Mn -4.84%

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.84%
Dec 31, 2025 32.98%
Sep 30, 2025 -95.06%
Jun 30, 2025 -58.73%
Mar 31, 2025 -48.95%
Dec 31, 2024 -11.14%
Sep 30, 2024 -62.87%
Jun 30, 2024 -3.02%
Mar 31, 2024 -131.90%
Dec 31, 2023 33.22%
Sep 30, 2023 -71.28%
Jun 30, 2023 -167.97%
Mar 31, 2023 -85.57%
Dec 31, 2022 -27.44%
Sep 30, 2022 -59.35%
Jun 30, 2022 -19.07%
Mar 31, 2022 57.34%
Dec 31, 2021 97.48%
Sep 30, 2021 -369.31%
Jun 30, 2021 -61.78%